Tumescent Lidocaine Maximum Safe mg/kg Dosage
Status unconfirmed · Phase 1/Phase 2
Conditions studied: Anesthesia
In brief
This pharmacokinetic clinical trial is a dose ranging study of lidocaine in tumescent local anesthesia. The goal is to understand the absorption pharmacokinetic of tumescent lidocaine and to determine an objective (statistical) estimate of the maximum safe mg/kg dosage of lidocaine in tumescent local anesthesia without liposuction.
Key facts
- Study ID
- NCT00977028
- Run by
- Klein, Jeffrey A., M.D.
- People needed
- 14
- Starts
- 2005-01-01
- Expected to finish
- 2011-08-01
- Last updated by the study team
- 2011-06-16
Who can join
Age: 18 and older, up to 72. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Healthy female (ASA class 1 or 2)
- Desires liposuction
- Easily accessible veins
You may not qualify if…
- History of Hepatitis C, HIV
- ASA class greater or equal to 3
Where it is running
- Capistrano Surgery Center — San Juan Capistrano, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.